Entero Therapeutics, Inc. (ENTO)
USD 0.56
(-0.74%)
USD 0.56
(-0.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.37 Million | -22.34 Million | -32.28 Million | -11.22 Million | -14.03 Thousand | -10.86 Million |
| Net Income | -15.79 Million | -14.62 Million | -58.53 Million | -32.67 Million | -15.17 Thousand | -13.53 Million |
| Depreciation & Amortization | 29.27 Thousand | 29.27 Thousand | 542.25 Thousand | 565.34 Thousand | 635.05 | 798.44 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.04 Million | 769.12 Thousand | 1.37 Million | 549.42 Thousand | 1391.93 | 2841.07 |
| Change in working capital | 2.19 Million | -10.5 Million | 17.1 Million | 14.15 Million | -1280.20 | -1.71 Million |
| Other non-cash items | 157.02 Thousand | 277.42 Thousand | 3.46 Million | 5.39 Million | 397.41 | 6.62 Million |
| Investing Cash Flow | -500 Thousand | - | -10.31 Million | 87.35 Thousand | -24.10 | -305.47 Thousand |
| Investments in PPE | -500 Thousand | - | -10.31 Million | -4167.00 | -24.09 Thousand | -305.47 Thousand |
| Acquisitions | - | - | - | 91.51 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -500.00 | - | -10.25 Thousand | 91.52 | - | - |
| Financing Cash Flow | 15.22 Million | 15.73 Million | 44.76 Million | 17.04 Million | 13.14 Thousand | 11.71 Million |
| Debt repayment | -603.49 Thousand | -641.23 Thousand | -88.83 Thousand | -2.86 Million | -3.6 Million | -190.67 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 15.82 Million | 23.04 Million | 32.66 Million | 988.34 Thousand | 9.47 Million | 11.9 Million |
| Other Financing Activities | 15.22 Thousand | -6.91 Million | 44.76 Thousand | 17.04 Thousand | 61.59 Thousand | 11.71 Thousand |
| Accounts receivables | 93.01 | -93.01 | 551.49 | 2083.27 | -749.86 | -2.18 Million |
| Accounts payables | -165.76 Thousand | -1.98 Million | 1.41 Million | -750.02 Thousand | -420.78 Thousand | 741.62 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2263.11 | -8420.92 | 15.13 Thousand | 12.81 Thousand | -444.66 Thousand | -265.52 Thousand |
| Cash at beginning of period | 1.38 Million | 8.24 Million | 6.06 Million | 175.79 Thousand | 1114.34 | 573.47 Thousand |
| Cash at end of period | 3.73 Million | 1.38 Million | 8.24 Million | 6.06 Million | 175.80 | 1.11 Million |
| Capital Expenditure | -500 Thousand | - | -10.31 Million | -4167.00 | -24.09 Thousand | -305.47 Thousand |
| Effect of forex changes on cash | - | -259.71 Thousand | 30.75 Thousand | -25.58 Thousand | -25.93 | 3.54 |
| Net cash flow / Change in cash | 2.34 Million | -6.86 Million | 2.18 Million | 5.88 Million | -938.55 | 540.87 Thousand |
| Free Cash Flow | -12.87 Million | -22.34 Million | -42.6 Million | -11.22 Million | -38.13 Thousand | -11.17 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.8 Million | 5.56 Million | -15.79 Million | -4.1 Million | -3.43 Million | -4.18 Million |
| Depreciation & Amortization | 35.31 Thousand | 12.29 Thousand | 29.27 Thousand | 7319.00 | 7318.00 | 7319.00 |
| Deferred income taxes | 4.25 Million | -14.85 Million | - | - | - | - |
| Stock-based compensation | 131.89 Thousand | 271.36 Thousand | 1.04 Million | 126.12 Thousand | 263.33 Thousand | 292.7 Thousand |
| Change in working capital | 147.86 Thousand | 451.14 Thousand | 2.19 Million | 494.52 Thousand | -259.79 Thousand | 1.11 Million |
| Other non-cash items | 786.52 Thousand | 4.81 Million | 157.02 Thousand | 33.59 Thousand | 92.09 Thousand | 15.8 Thousand |
| Investing Cash Flow | - | 88.16 Thousand | -500 Thousand | -500.00 | - | - |
| Investments in PPE | - | -4.00 | -500 Thousand | -500 Thousand | - | - |
| Acquisitions | - | 88.16 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -500.00 | -500.00 | - | - |
| Financing Cash Flow | 681.42 Thousand | 3.37 Million | 15.22 Million | 4.35 Million | 5.38 Million | 1.93 Million |
| Debt repayment | -209.2 Thousand | -226.01 Thousand | -603.49 Thousand | - | -153.47 Thousand | -226.91 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 890.59 Thousand | 3.6 Million | 15.82 Million | 10.3 Million | 1.83 Million | -78.93 Thousand |
| Other Financing Activities | 36.00 | 3378.93 | 15.22 Thousand | 4358.82 | 5387.49 | 1933.30 |
| Accounts receivables | - | - | 93.01 | - | - | 20.00 |
| Accounts payables | 218.56 Thousand | 526.03 Thousand | -165.76 Thousand | -25.01 Thousand | -1.01 Million | 1.12 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -70.69 Thousand | -74.89 | 2263.11 | 519.54 | 752.11 | -29.72 |
| Cash at beginning of period | 3.45 Million | 3.73 Million | 1.38 Million | 3.31 Million | 1.25 Million | 2.08 Million |
| Cash at end of period | 683.99 Thousand | 3.45 Million | 3.73 Million | 3.73 Million | 3.31 Million | 1.25 Million |
| Capital Expenditure | - | -4.00 | -500 Thousand | -500 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.76 Million | -279.85 Thousand | 2.34 Million | 419.44 Thousand | 2.05 Million | -828.38 Thousand |
| Free Cash Flow | -3.45 Million | -3.74 Million | -12.87 Million | -3.93 Million | -3.33 Million | -2.76 Million |
AVEFF
UV-R
1979
FFWM
4533
2322